Discover
CTEV
Claritev Corporation
30.81
200 x undefined
100 x undefined
bid
ask
-
0.92
2.90%
150 @ 04:01 AM
30.81 +0.00 (0.00%)
| Ytd | -27.93% | |
| 1y | -44.38% |
30.81
day range
32.03
11.50
52 week range
73.68
| Open | 31.81 | Prev Close | 31.73 | Low | 30.81 | High | 32.03 | Mkt Cap | 522.15M |
| Vol | 299.23K | Avg Vol | 125.01K | EPS | -17.00 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.58 | Short Ratio | 5.04 | Inst. Own | 87.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 32.46 | 200-d Avg | 27.66 | 1yr Est | 70.50 |
CTEV News
gurufocus.com
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100
On September 17, 2026, Claritev Corp (CTEV) shares fell 5.5%, bringing the current price to $31.73.
businesswire.com
Claritev Releases 2025 Corporate Responsibility Report
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #CommunityImpact--Claritev Corporation ("Claritev" or the "Co
seekingalpha.com
Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tran
Claritev Corporation (CTEV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tran
businesswire.com
Claritev Appoints Ben Letham to its Board of Directors
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #BoardOfDirectors--Claritev Corporation (“Claritev” or the “C
benzinga.com
Barclays Maintains Overweight on Claritev, Raises Price Target to $40
Barclays analyst Glen Santangelo maintains Claritev (NYSE:CTEV) with a Overweight and raises the